First Time Loading...
L

Lepu Biopharma Co Ltd
HKEX:2157

Watchlist Manager
Lepu Biopharma Co Ltd
HKEX:2157
Watchlist
Price: 6.41 HKD 3.55% Market Closed
Updated: May 5, 2024

Lepu Biopharma Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lepu Biopharma Co Ltd
Cash from Investing Activities Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
L
Lepu Biopharma Co Ltd
HKEX:2157
Cash from Investing Activities
-¥74.7m
CAGR 3-Years
54%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Investing Activities
¥2.4B
CAGR 3-Years
-22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash from Investing Activities
-¥1.1B
CAGR 3-Years
41%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Investing Activities
-¥2.1B
CAGR 3-Years
-91%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Investing Activities
-¥993.8m
CAGR 3-Years
-10%
CAGR 5-Years
-18%
CAGR 10-Years
-14%
Imeik Technology Development Co Ltd
SZSE:300896
Cash from Investing Activities
-¥943.7m
CAGR 3-Years
-233%
CAGR 5-Years
-143%
CAGR 10-Years
N/A

See Also

What is Lepu Biopharma Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-74.7m CNY

Based on the financial report for Dec 31, 2023, Lepu Biopharma Co Ltd's Cash from Investing Activities amounts to -74.7m CNY.

What is Lepu Biopharma Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
54%

Over the last year, the Cash from Investing Activities growth was 0%. The average annual Cash from Investing Activities growth rates for Lepu Biopharma Co Ltd have been 54% over the past three years .